BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 36444510)

  • 1. Cost-effectiveness analysis of hydrophilic-coated catheters in long-term intermittent catheter users in the UK.
    Baker H; Avey B; Overbeck Rethmeier L; Mealing S; Lynge Buchter M; Averbeck MA; Thiruchelvam N
    Curr Med Res Opin; 2023 Feb; 39(2):319-328. PubMed ID: 36444510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of hydrophilic-coated intermittent catheters compared with uncoated catheters in Canada: a public payer perspective.
    Welk B; Isaranuwatchai W; Krassioukov A; Husted Torp L; Elterman D
    J Med Econ; 2018 Jul; 21(7):639-648. PubMed ID: 29458282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare resource consumption for intermittent urinary catheterisation: cost-effectiveness of hydrophilic catheters and budget impact analyses.
    Rognoni C; Tarricone R
    BMJ Open; 2017 Jan; 7(1):e012360. PubMed ID: 28096251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-Effectiveness Analysis of Long-Term Intermittent Self-Catheterization with Hydrophilic-Coated and Uncoated Catheters in Patients with Spinal Cord Injury in Japan.
    Watanabe T; Yamamoto S; Gotoh M; Saitoh T; Yokoyama O; Murata T; Takeda M
    Low Urin Tract Symptoms; 2017 Sep; 9(3):142-150. PubMed ID: 28868661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short-term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial- and antiseptic-impregnated urethral catheters (the CATHETER trial).
    Pickard R; Lam T; Maclennan G; Starr K; Kilonzo M; McPherson G; Gillies K; McDonald A; Walton K; Buckley B; Glazener C; Boachie C; Burr J; Norrie J; Vale L; Grant A; N'dow J
    Health Technol Assess; 2012 Nov; 16(47):1-197. PubMed ID: 23199586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can hydrophilic coated catheters be beneficial for the public healthcare system in Brazil? - A cost-effectiveness analysis in patients with spinal cord injuries.
    Truzzi JC; Teich V; Pepe C
    Int Braz J Urol; 2018; 44(1):121-131. PubMed ID: 28792195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermittent self catheterisation with hydrophilic, gel reservoir, and non-coated catheters: a systematic review and cost effectiveness analysis.
    Bermingham SL; Hodgkinson S; Wright S; Hayter E; Spinks J; Pellowe C
    BMJ; 2013 Jan; 346():e8639. PubMed ID: 23303886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A scoping review on the impact of hydrophilic versus non-hydrophilic intermittent catheters on UTI, QoL, satisfaction, preference, and other outcomes in neurogenic and non-neurogenic patients suffering from urinary retention.
    Barken KB; Vaabengaard R
    BMC Urol; 2022 Sep; 22(1):153. PubMed ID: 36123663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent Catheters for Chronic Urinary Retention: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2019; 19(1):1-153. PubMed ID: 30847008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cost-effectiveness analysis of long-term intermittent catheterisation with hydrophilic and uncoated catheters.
    Clark JF; Mealing SJ; Scott DA; Vogel LC; Krassioukov A; Spinelli M; Bagi P; Wyndaele JJ
    Spinal Cord; 2016 Jan; 54(1):73-7. PubMed ID: 26193812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized Crossover Trial of Single Use Hydrophilic Coated vs Multiple Use Polyvinylchloride Catheters for Intermittent Catheterization to Determine Incidence of Urinary Infection.
    Kiddoo D; Sawatzky B; Bascu CD; Dharamsi N; Afshar K; Moore KN
    J Urol; 2015 Jul; 194(1):174-9. PubMed ID: 25584995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cost-effectiveness analysis of bladder management strategies in neurogenic lower urinary tract dysfunction after spinal cord injury: A publicly funded health care perspective.
    Shamout S; Nazha S; Dragomir A; Baverstock R; Corcos J; Campeau L
    Spinal Cord; 2023 Apr; 61(4):269-275. PubMed ID: 36894764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrophilic catheters for intermittent catheterization and occurrence of urinary tract infections. A retrospective comparative study in patients with spinal cord Injury.
    Ali S; Khan OS; Youssef AM; Saba I; Alfedaih D
    BMC Urol; 2024 Jun; 24(1):122. PubMed ID: 38867233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrophilic catheters: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(9):1-31. PubMed ID: 23074500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent catheterisation for long-term bladder management.
    Prieto J; Murphy CL; Moore KN; Fader M
    Cochrane Database Syst Rev; 2014 Sep; (9):CD006008. PubMed ID: 25208303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost effectiveness of antimicrobial catheters for adults requiring short-term catheterisation in hospital.
    Kilonzo M; Vale L; Pickard R; Lam T; N'Dow J;
    Eur Urol; 2014 Oct; 66(4):615-8. PubMed ID: 24958624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of onabotulinumtoxinA (BOTOX(®)) for the management of urinary incontinence in adults with neurogenic detrusor overactivity: a UK perspective.
    Hamid R; Loveman C; Millen J; Globe D; Corbell C; Colayco D; Stanisic S; Gultyaev D
    Pharmacoeconomics; 2015 Apr; 33(4):381-93. PubMed ID: 25526842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WITHDRAWN: Intermittent catheterisation for long-term bladder management.
    Prieto J; Murphy CL; Moore KN; Fader M
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD006008. PubMed ID: 28796279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of hydrophilic-coated urinary catheters for individuals with spinal cord injury: A systematic review.
    Xi M; Elterman DS; Welk B; Pakosh M; Chan BCF
    BJUI Compass; 2021 Mar; 2(2):71-81. PubMed ID: 35474888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model.
    Sutcliffe P; Connock M; Pulikottil-Jacob R; Kandala NB; Suri G; Gurung T; Grove A; Shyangdan D; Briscoe S; Maheswaran H; Clarke A
    Health Technol Assess; 2013 Nov; 17(53):1-499, v-vi. PubMed ID: 24280231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.